The initial success of Viagra undeniably reshaped the medication landscape, but placing funds in companies heavily reliant on off-patent versions presents a uncertain picture. Although early profits were impressive, the expiration of patents and the emergence of discounted alternatives have weakened market share. Consequently, a thorough evaluation